Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey.

Autopsy European Heart Rhythm Association survey Genetic testing Inherited cardiac conditions Provocation testing Sudden Arrhythmic Death Syndrome Sudden Unexplained Death in the Young Sudden death

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
02 02 2022
Historique:
received: 22 06 2021
accepted: 25 06 2021
pubmed: 6 8 2021
medline: 31 3 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

The aims of this centre-based survey, promoted and disseminated by the European Heart Rhythm Association (EHRA) was to investigate the current practice for the investigation of Sudden Unexplained Death in the Young (SUDY) amongst European countries. An online questionnaire composed of 21 questions was submitted to the EHRA Research Network, European Cardiac Arrhythmia Genetics (ECGen) Focus Group members, and European Reference Network GUARD-Heart healthcare partners. There were 81 respondents from 24 European countries. The majority (78%) worked in a dedicated clinic focusing on families with inherited cardiac conditions and/or SUDY or had easy access to a nearby one. On average, an autopsy was performed in 43% of SUDY cases. Macroscopic examination of the body and all organs were completed in 71% of cases undergoing autopsy, and expert cardiac examination in 32%. Post-mortem genetic testing was requested on average in 37% of Sudden Arrhythmic Death Syndrome (SADS) cases, but not at all by 20% of survey respondents. Psychological support and bereavement counselling for SADS/SUDY families were available for ≤50% of participants. Whilst electrocardiogram (ECG) and echocardiography were largely employed to investigate SADS relatives, there was an inconsistent approach to the use of provocative testing with exercise ECG, sodium channel blocking drugs, and/or epinephrine and genetic testing. The survey highlighted a significant heterogeneity of service provision and variable adherence to current recommendations for the investigation of SUDY, partly attributable to the availability of dedicated units and specialist tests, genetic evaluation, and post-mortem examination.

Identifiants

pubmed: 34351417
pii: 6341858
doi: 10.1093/europace/euab176
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-339

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Elijah R Behr (ER)

Cardiology Research Centre and Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
St. George's University Hospitals NHS Foundation Trust, London, UK.

Chiara Scrocco (C)

Cardiology Research Centre and Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
St. George's University Hospitals NHS Foundation Trust, London, UK.

Arthur A M Wilde (AAM)

Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam UMC, Location Academic Medical Center, Amsterdam, The Netherlands.

Eloi Marijon (E)

Paris Cardiovascular Research Center, INSERM Unit 970, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Cardiology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.

Lia Crotti (L)

Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, San Luca Hospital, Milan, Italy.
Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Laboratory of Cardiovascular Genetics, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Konstantinos E Iliodromitis (KE)

Evangelisches Krankenhaus Hagen-Haspe, Clinic for Cardiology and Electrophysiology, Hagen, Germany.

Carol A Remme (CA)

Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam UMC, Location Academic Medical Center, Amsterdam, The Netherlands.

Jedrzej Kosiuk (J)

1st Chair and Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Irina Rudaka (I)

Arrhythmology Department, Paul Stradins Clinical University Hospital, Riga Stradins University, Riga, Latvia.

Georgia Sarquella Brugada (GS)

Arrhythmia, Inherited Cardiac Diseases and Sudden Death, Hospital Sant Joan de Déu, Barcelona, Spain.
Medical Sciences Department, School of Medicine, University of Girona, Girona, Spain.

Katie Frampton (K)

Cardiology Research Centre and Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
St. George's University Hospitals NHS Foundation Trust, London, UK.

Eric Schulze-Bahr (E)

Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.

Kristine Jubele (K)

Arrhythmology Department, Paul Stradins Clinical University Hospital, Riga Stradins University, Riga, Latvia.

Carlo de Asmundis (C)

Heart Rhythm Management Center, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.

Nynke Hofman (N)

Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam UMC, Location Academic Medical Center, Amsterdam, The Netherlands.

Jacob Tfelt-Hansen (J)

The Heart Centre, Department of Cardiology, Copenhagen University Hospital/Rigshospitalet, Copenhagen, Denmark.
Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.

Serge Boveda (S)

Paris Cardiovascular Research Center, INSERM Unit 970, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Heart Rhythm Management Center, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, Brussels, Belgium.
Heart Rhythm Management Department, Clinique Pasteur, 45 Avenue de Lombez, 31076 Toulouse, France.

Giulio Conte (G)

Division of Cardiology, Cardiocentro Ticino Institute, Lugano, Switzerland.
Università della Svizzera Italiana Lugano, Lugano, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH